Literature DB >> 10163465

Long-term results of pars plana vitrectomy in the management of intermediate uveitis.

A Heiligenhaus1, N Bornfeld, A Wessing.   

Abstract

Pars plana vitrectomy is a useful tool for the management of certain complications in chronic intermediate uveitis. Media opacities obscuring the visual axis, vitreous membranes causing tractional retinal detachment, macular puckers, and ciliary traction leading to hypotony are clear indications for this approach. Furthermore, it has been suggested that vitrectomy may have a favorable long-term effect on the course of disease. The procedure may achieve regression of inflammation, tapering of immunosuppression, and improvement of cystoid macular edema. However, randomized prospective trials are still needed to define the role of vitrectomy in altering the course of uveitis.

Entities:  

Mesh:

Year:  1996        PMID: 10163465     DOI: 10.1097/00055735-199606000-00013

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  7 in total

Review 1.  [Surgery for macular edema].

Authors:  C Haritoglou; A Kampik
Journal:  Ophthalmologe       Date:  2004-06       Impact factor: 1.059

2.  The effect of pars plana vitrectomy on cystoid macular oedema associated with chronic uveitis: a randomised, controlled pilot study.

Authors:  P Tranos; R Scott; H Zambarakji; H Zambarajki; W Ayliffe; C Pavesio; D G Charteris
Journal:  Br J Ophthalmol       Date:  2006-05-24       Impact factor: 4.638

3.  Long-term evaluation of dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to non-infectious uveitis.

Authors:  L Pelegrín; M S de la Maza; B Molins; J Ríos; A Adán
Journal:  Eye (Lond)       Date:  2015-05-22       Impact factor: 3.775

4.  Pars plana vitrectomy with intravitreal triamcinolone: effect on uveitic cystoid macular oedema and treatment limitations.

Authors:  Matthias Gutfleisch; Georg Spital; Anne Mingels; Daniel Pauleikhoff; Albrecht Lommatzsch; Arnd Heiligenhaus
Journal:  Br J Ophthalmol       Date:  2006-09-27       Impact factor: 4.638

5.  Remission of Intermediate Uveitis: Incidence and Predictive Factors.

Authors:  John H Kempen; Dina Y Gewaily; Craig W Newcomb; Teresa L Liesegang; R Oktay Kaçmaz; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; H Nida Sen; Eric B Suhler; Jennifer E Thorne; C Stephen Foster; Douglas A Jabs; Abhishek Payal; Tonetta D Fitzgerald
Journal:  Am J Ophthalmol       Date:  2016-01-06       Impact factor: 5.258

Review 6.  [Therapeutic vitrectomy in uveitis: current status and recommendations].

Authors:  M D Becker; N Harsch; M Zierhut; J L Davis; F G Holz
Journal:  Ophthalmologe       Date:  2003-10       Impact factor: 1.059

Review 7.  Intravitreal Dexamethasone Implant in the Treatment of Non-Infectious Uveitic Macular Edema.

Authors:  Omer Karti; Ali Osman Saatci
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2018
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.